Cargando…
Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients
BACKGROUND: Most gastric cancer (GC) patients are diagnosed at middle or late stage because the symptoms in early stage are obscure, which causes higher mortality rates of GC. Helicobacter pylori (H. pylori) was identified as a class I carcinogen and leads to aberrant DNA methylation/hydroxymethylat...
Autores principales: | Fu, Ying-Li, Wu, Yan-Hua, Cao, Dong-Hui, Jia, Zhi-Fang, Shen, Ao, Jiang, Jing, Cao, Xue-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305580/ https://www.ncbi.nlm.nih.gov/pubmed/36051102 http://dx.doi.org/10.4251/wjgo.v14.i7.1295 |
Ejemplares similares
-
Helicobacter pylori infection in subjects negative for high titer serum antibody
por: Toyoshima, Osamu, et al.
Publicado: (2018) -
Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori
por: Yamada, Shinya, et al.
Publicado: (2016) -
Disease trends after Helicobacter pylori eradication based on Japanese nationwide claims and the health check-up database
por: Mizukami, Kazuhiro, et al.
Publicado: (2023) -
Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019) -
Evaluation of antibiotic resistance of Helicobacter pylori bacteria obtained from gastric biopsy samples: A cohort study()
por: Azadbakht, Saleh, et al.
Publicado: (2022)